Literature DB >> 7882273

Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ.

D L Page, M D Lagios.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7882273     DOI: 10.1002/1097-0142(19950315)75:6<1219::aid-cncr2820750602>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Why I became a surgical pathologist with interest in breast disease.

Authors:  David L Page
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

Review 2.  Ductal carcinoma in situ of the breast.

Authors:  M J Silverstein
Journal:  BMJ       Date:  1998-09-12

3.  [Prognostic factors in ductal carcinoma in situ].

Authors:  A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

4.  Cure, conservation, confusion, chaos.

Authors:  M J Silverstein
Journal:  West J Med       Date:  1995-10

Review 5.  Current management of ductal carcinoma in situ.

Authors:  A Barth; R J Brenner; A E Giuliano
Journal:  West J Med       Date:  1995-10

6.  Evaluation of resection margins in breast conservation therapy: the pathology perspective-past, present, and future.

Authors:  Rajyasree Emmadi; Elizabeth L Wiley
Journal:  Int J Surg Oncol       Date:  2012-11-19

7.  Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.

Authors:  A Gandhi; P A Holland; W F Knox; C S Potten; N J Bundred
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.